ÂÜÀòÂÒÂ×

Mr. Anderson is a Partner, Head of Research and a co-founding member of Cowen Healthcare Investments. Mr. Anderson focuses on investments in biotechnology, diagnostics and digital medicine companies that have the potential to meaningfully address serious medical conditions. He is currently a member of the Board of Directors of Lycia Therapeutics, F2G, Anaveon AG and Autobahn Therapeutics. Mr. Anderson previously served as a Board Member or Board Observer of Vectiv Bio Holdings AG, Therachon Holdings AG, Precision Biosciences, Livongo Health, Cadent Therapeutics, Cullinan Oncology and Compass Therapeutics. He is also a current member of the Investment Committee of Lagunita Biosciences. Prior to his role at Cowen Healthcare Investments, Mr. Anderson was a biotechnology investment banker on Cowen’s healthcare investment banking team.

Mr. Anderson holds a BA in economics from Bowdoin College.